132875-69-5

Basic information

• Product Name: 1-(2-Carboxy-ethyl)-4-(phenyl-propionyl-amino)-piperidine-4-carboxylic acid methyl ester; compound with trifluoro-acetic acid
• Synonyms: 1-(2-Carboxy-ethyl)-4-(phenyl-propionyl-amino)-piperidine-4-carboxylic acid methyl ester; compound with trifluoro-acetic acid
• CAS NO: 132875-69-5
• Molecular Weight: 476.45
• Mol File: 132875-69-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-(2-Carboxy-ethyl)-4-(phenyl-propionyl-amino)-piperidine-4-carboxylic acid methyl ester; compound with trifluoro-acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-Carboxy-ethyl)-4-(phenyl-propionyl-amino)-piperidine-4-carboxylic acid methyl ester; compound with trifluoro-acetic acid(132875-69-5)
• EPA Substance Registry System: 1-(2-Carboxy-ethyl)-4-(phenyl-propionyl-amino)-piperidine-4-carboxylic acid methyl ester; compound with trifluoro-acetic acid(132875-69-5)

Safety Data

• Hazardous Substances Data: 132875-69-5(Hazardous Substances Data)

Upstream product

• 1159835-40-1 1-tert-butyl 4-methyl 4-(N-phenylpropionamido)piperidine-1,4-dicarboxylate 
• 1159835-31-0 1-(tert-butoxycarbonyl)-4-(phenylamino)piperidine-4-carboxylic acid 
• 62-53-3 aniline 
• 61085-73-2 Methyl 4-[N-(1-oxopropyl)-N-phenylamino]-1-(phenylmethyl)-4-piperidinecarboxylate oxalate 
• 61085-72-1 methyl 4-[N-(1-oxopropyl)-N-phenylamino]-1-benzyl-4-piperidinecarboxylate 
• 130819-94-2 1-benzyl-4-(propionanilido)piperidine-4-carbonitrile 
• 968-86-5 1-benzyl-4-(phenylamino)piperidine-4-carbonitrile 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 72996-78-2 methyl 4-[N-(1-oxopropyl)-N-phenylamino]-4-piperidinecarboxylate 
• 132876-50-7 1-(2-tert-Butoxycarbonyl-ethyl)-4-(phenyl-propionyl-amino)-piperidine-4-carboxylic acid methyl ester 
• 76-05-1 trifluoroacetic acid 

Relevant articles and documents

FENTANYL HAPTENS, FENTANYL HAPTEN CONJUGATES, AND METHODS FOR MAKING AND USING

This disclosure describes fentanyl haptens, a fentanyl hapten-carrier conjugate, methods of making the fentanyl hapten-carrier conjugate, and methods of using the fentanyl hapten-carrier conjugate including, for example, as a prophylactic vaccine to counteract toxicity from exposure to fentanyl, fentanyl derivatives, and fentanyl analogs. In some embodiments, the fentanyl hapten-carrier conjugate or a composition including the fentanyl hapten-carrier conjugate may be used in an anti-opioid vaccine.